Halofuginone is a low molecular weight quinazolinone alkaloid that acts as an inhibitor of collagen alpha1(I) and matrix metalloproteinase 2 gene expression. It is being developed as a pharmaceutical active ingredient for research into fibrotic conditions and cancer metastasis.
콘텐츠 범위: 이 페이지의 정보는 화학물질 식별 및 산업 공급·연구개발·제조 맥락을 대상으로 합니다. 치료 효능 주장, 의료 조언 또는 의약품 사용 지침에 해당하지 않습니다.
이 화합물을 구매하거나 공급하시겠습니까?
재고를 등록하거나 구매 요청을 게시하세요
CAS 868851-54-1
Halofuginone hydrobromide
active pharmaceutical ingredient
Halofuginone lactate
Active pharmaceutical ingredient
Umeclidinium bromide
muscarinic antagonist active pharmaceutical ingredient
Neurokinin B
tachykinin receptor ligand
OLODATEROL HYDROCHLORIDE
beta-adrenergic agonist bronchodilator
Tecovirimat
antiviral active pharmaceutical ingredient
(-)-Halofuginone
active pharmaceutical ingredient
7-bromo-6-chloro-3-[3-[(2R,3S)-3-hydroxypiperidin-2-yl]-2-oxopropyl]quinazolin-4-one
LVASCWIMLIKXLA-CABCVRRESA-N
C1C[C@@H]([C@H](NC1)CC(=O)CN2C=NC3=CC(=C(C=C3C2=O)Cl)Br)O